Illumina Inc (USD)
ILMN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range369.90 | 374.23
52-Wk Range- | -
Last Close370.25
Mkt Cap (m)54,426.75
Dividend yield-
ISINUS4523271090
Volume570,988.00
Exchange VenueNAS

Company Profile

Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products.

Key Information
Price/Earning58.40
Price/Book11.74
Price/Sales15.49
P/CF48.57
Rev Growth (3 year avg)13.89
EPS Growth (3 year avg)0.30
Operating Margin % 27.80
Net Margin %28.28
Return on Equity23.94
Debt/Equity0.41

Documents

Annual Report
en 29/12/2019

Please refer to the below issuer website for further documents.

https://www.illumina.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)1,861.362,219.762,398.372,752.003,333.003,543.00
Operating Income (m)443.37623.11579.03606.00883.00985.00
Net Income (m)353.35461.56462.65726.00826.001,002.00
Basic EPS2.613.193.094.965.636.81
Avg. Diluted Shares Outstanding (m)148.98149.07148.04148.00149.00149.00
Balance Sheet
USD201420152016201720182019
Current Assets (m)1,889.602,096.822,318.092,980.004,490.004,451.00
Non Current Assets (m)1,450.041,590.921,962.512,277.002,469.002,865.00
Total Assets (m)3,339.643,687.754,280.605,257.006,959.007,316.00
Current Liabilities (m)722.16610.49704.67746.001,804.00665.00
Total Liabilities (m)------
Total Equity (m)1,462.801,848.552,197.232,749.003,758.004,613.00
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)501.27659.60687.24875.001,142.001,051.00
Capital Expenditure (m)-142.22-143.25-271.38-312.00-296.00-209.00
Figures are quoted in USD unless stated otherwise
-
No change
$
370.25
Last Price